OVERVIEW

Cell & Gene Therapy USA 2022 is organized by Reuters Events Pharma and will be held from Sep 20 - 21, 2022.

Theme: One giant commercial leap for cell and gene therapies

Description:
Formulate, scale and standardize out-of-this-world launch strategies to bring your cell and gene therapies to market fast and effectively
While some developers are implementing lessons learned – and launching – their 2nd cell and gene therapies to market, the majority are hoping the launch strategy for their 1st holds strong, as they navigate through a meteor shower of risky unknowns, firsts, new partnerships, and complexities the average pharma team has never experienced before.
To succeed commercially, pharma and biotech need to formulate a launch strategy that engages the right commercial resource early on, rewrites traditional payment models in partnership with payers, and provides an integrated delivery network that scales up seamlessly, end-to-end.
By attending Reuters Events: Cell & Gene Therapy USA, you will hear learnings from those who have already achieved lift off. C-suite, commercial strategy, manufacturing and supply, pricing and access experts provide attendees with the tools to launch successfully and sustain and scale your cell and gene therapy delivery into hyperdrive.